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Abstract
The prospective comparative case series aimed to evaluate the binocular uncorrected visual
acuities (BUCVAs) after staged implantations of extended-depth-of-focus intraocular lenses
(EDOF IOLs) targeting emmetropia and -0.5 diopter (D). Diffractive EDOF IOLs with an add
power of +1.75 D were implanted in the first eyes targeting emmetropia or -0.5 D according
to the patients’ preferences, then the targets for the second eyes were determined 1 week
or longer after the implantation. IOL powers were determined with the SRK/T formula. Con-
sequently, the subjects were divided into 3 groups: those with emmetropia targeted bilater-
ally (group EE, 22 patients), those with -0.5 D targeted bilaterally (group MM, 21 patients),
and those with monovision of emmetropia and -0.5 D (group EM, 21 patients). Manifest
refraction spherical equivalent (MRSE), BUCVA from 0.3 to 5 meters, spectacle use, and
questionnaire regarding photic symptoms and patient satisfaction were assessed 3 months
postoperatively. No significant differences were seen in the mean BUCVAs at any distance
(P > 0.23), spectacle use (P = 0.13), or photic symptoms and patient satisfaction (P>0.65).
When the EE and MM groups were assigned based on the MRSE, the EE group was better
at 5 m (P = 0.005) while the MM group at 0.5 m (P = 0.031). The effect of different targeted
refractions was not identified due to insufficient accuracy in the use of the SRK/T power
calculation.
Introduction
Multifocal intraocular lenses (IOLs) with two foci are used to correct presbyopia in patients
undergoing cataract surgery. Resultant good visual acuities at far and near distances have been
achieved and postoperative spectacle dependence decreased [1–3]. However, the risks of pho-
tic phenomena inherent in the use of bifocal optics are concerns. Extended depth-of-focus
(EDOF) is an alternative concept of presbyopia-correcting IOLs. The continuous extension of
the depth of focus in distance vision toward intermediate distances can be obtained, and no
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secondary focus minimizes photic phenomena [4]. A diffractive EDOF IOL with an echelle
grating is available commercially. The first-order diffraction constitutes the focus for far dis-
tance vision, and the second-order diffraction produces a focus of +1.75 diopters (D) higher
than the far focus. The two foci of the small refractive differences consequently prolong the
range of vision from far to intermediate distances. Thus, the visual outcomes at a near distance
such as 0.3 m are fundamentally lower than with multifocal IOLs with a 4.0-D add power. To
compensate for insufficient near vision, monovision has been considered with the targeted
refractions of emmetropia and slight myopia [5–7]. A multicenter prospective case series of
411 patients demonstrated that monovision effectively improved the binocular near visual acu-
ities compared with binocular emmetropia [5]. Although the defocus curve indicates the
potential for a longer range by adjusting the targeted refraction [8], the effect of myopic target-
ing has not been assessed. The current prospective comparative case series evaluated the binoc-
ular visual outcomes after staged implantation of diffractive EDOF IOLs for three targeted




The institutional review board of Tokyo Dental Collage (identifier, 800) approved the study
protocol. All patients provided written informed consent after explanation of the study, and
the study was conducted according to the tenets of the Declaration of Helsinki. Patients sched-
uled to undergo cataract surgery with bilateral EDOF IOL implantation were recruited. Eye
for which the postoperative astigmatism would be anticipated to be over 1.25 D were excluded.
The exclusion criteria also included a previous ocular surgery; chronic or recurrent uveitis;
acute ocular disease or external/internal infection; diabetes with retinal changes; glaucoma;
exfoliation syndrome; pathological miosis; keratoconus; corneal endothelial dystrophy; and
capsular, zonular, and pupillary abnormalities.
Implanted EDOF IOLs
All patients underwent cataract removal and implantation of a one-piece, violet light blocking,
hydrophobic acrylic, diffractive EDOF IOLs with an add power of +1.75 D (model ZXR00V,
Johnson & Johnson Surgical Vision, Santa Ana, CA). The diffractive optics was designed for
providing visual acuity in the range of 0.7 meter to far distances [4,9]. The IOL optics of
6.0-mm diameter had aspheric design on the front surface, continuous sharp optic edges on
the posterior, and anteriorly shifted haptics. As the IOL was not optimized for the Barrett Uni-
versal II formula (http://calc.apacrs.org/barrett_universal2105/), the IOL power was deter-
mined using the SRK/T formula with axial length and keratometry values measured using the
IOLMaster 700 (Carl Zeiss Meditec, Inc., Dublin, CA).
Staged implantation
At first, the eye with advanced lens opacity or lower visual acuity was operated. Therefore, the
first eyes included both dominant and non-dominant eyes. After the cataracts were removed
using a LenSx1 Laser System (Version 2.23) and a Centurion Vision System (Alcon Laborato-
ries, Fort Worth, TX) by a phacoemulsification and aspiration technique [10], the IOLs were
implanted completely within the capsules using the IOL inserter system. The targeted refrac-
tion for the first eyes was either emmetropia or -0.5 D based on patient preference. With the
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target of a -0.5-D refraction, the better visual acuity around 50 centimeters was anticipated
[5–7].
After routine examinations 1 week or longer postoperatively, patients were asked for
their preference in the fellow eye (Fig 1). Based on patient preference and the outcomes in
the first eye, the targeted refraction for the fellow eye was determined to be emmetropia or
-0.5 D. When the patient selected a different targeted refraction, the effects and risks of
monovision were explained. For eyes targeting emmetropia, IOL powers for which the pre-
dicted refractions was negative number closest to 0.0 D were chosen to avoid postoperative
hyperopia. For eyes targeting -0.5 D, the powers for which the predicted refraction was clos-
est to -0.5 D were chosen. Consequently, the patients were divided into three groups based
on the choice of the targeted refractions: bilateral emmetropia (group EE), bilateral -0.5 D
(group MM), and emmetropia and -0.5 D (group EM). A minimal sample size was 19
patients in each group, which was required for detecting differences in the binocular uncor-
rected visual acuity (BUCVA) among the three groups with the significant level of 0.05 and
detection power of 0.75 when the effect size was 0.4 (corresponding to large in Cohen’s
classification).
Fig 1. Staged implantation of an extended-depth-of-focus intraocular lens (IOL, ZXR00V) targeting emmetropia and -0.5
diopter (D). The patients are divided into three groups based on the choice of the target refractions: bilateral emmetropia (group EE),
bilateral -0.5 D (group MM), and emmetropia and -0.5D (group EM).
https://doi.org/10.1371/journal.pone.0238135.g001
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Examinations
Three months postoperatively, the BUCVAs were measured at the distances of 5.0, 1.0, 0.7, 0.5,
and 0.3 meters and converted to the logarithm of the minimum angle of resolution (logMAR)
for analysis. The manifest refraction spherical equivalents (MRSEs) also were recorded monoc-
ularly during examinations of the best-corrected visual acuity at 5 meters. Patients were ques-
tioned about their spectacle use.
The near stereopsis was measured at 16 inches using the Titmus stereoscopic test under
photopic illumination. The numbers of answers for the three targets (fly, animal, and circle)
without refractive correction were converted to seconds of arc for analysis, with 100 seconds
of arc considered as the maximal limit of normal stereopsis [11,12].
Patient satisfaction and symptoms of photic phenomena were assessed through a question-
naire. Photic severities in glare, halos, starbursts, and low-contrast sensitivity were graded on a
scale of 1 to 4, with 1 indicating no symptoms, 2 mild/rare, 3 moderate/occasional, and 4
severe. Satisfaction with the overall, distance, intermediate, and near vision also was graded on
a scale of 1 to 4, with 1 indicating very unsatisfied, 2 unsatisfied, 3 satisfied, and 4 very satisfied.
The mean of each score was calculated.
Statistical analysis
Visual acuities, near stereopsis, patient satisfaction, and symptoms of phonic phenomena were
compared among the three groups using the Kruskal-Wallis test following the Steel-Dwass
multiple comparison test. The use of spectacles was evaluated using the Fisher’s exact test.
P<0.05 was considered significant.
Although the postoperative MRSEs were targeted to emmetropia (0.0 D) or -0.5 D, it was
difficult to achieve them with sufficiently small refractive errors. In recent assessments [13,14],
refractive errors of 0.5 D or less were achievable in approximately 70% of eyes. So, a sub-analy-
sis was conducted for exploring the effect of the -0.5 D targeted refractions. The EE and MM
groups were re-classified based on the postoperative MRSE: patients with the MRSEs in the
ranges of -0.25 to +0.25 D and -0.75 to -0.25 D were assigned to the EE and MM groups,
respectively. The BUCVAs of the patients were compared using the Mann-Whitney test.
Results
Groups EE, MM, and EM were comprised of 22, 21, and 21 patients, respectively. Table 1
shows the patient demographic data. There were no differences in the age and corneal
Table 1. Preoperative demographic data.
Group EE MM EM P value+
Targeted refractions 0.0 D x 2 -0.5 D x 2 0.0, -0.5 D
No. of patients 22 21 21
Age (years), range 69.6 ± 4.7, 59 to 82 65.0 ± 7.0, 51 to 79 68.2 ± 6.9, 55 to 81 0.072
Axial length (mm), range 24.0 ± 1.3�, 22.6 to 27.5 25.4 ± 1.8, 22.3 to 29.6 24.8 ± 1.5, 21.6 to 29.1 < 0.001
IOL power (D), range 20.4 ± 4.0�, 10.5 to 24.5 16.4 ± 5.4, 6.0 to 25.0 18.1 ± 4.5, 7.5 to 26.5 < 0.001
Corneal astigmatism (D), range 0.64 ± 0.37, 0.06 to 1.41 0.74 ± 0.39, 0.06 to 1.71 0.66 ± 0.38, 0.05 to 1.72 0.43
The data are expressed as the mean ± standard deviation.
+: Kruskal-Wallis test.
�: Significant difference between the MM and EM groups (P<0.017, the Steel-Dwass multiple comparison).
EE = bilateral emmetropia; MM = bilateral -0.5 D bilaterally; EM = monovision of emmetropia and -0.5 D; IOL = intraocular lens; D = diopters.
https://doi.org/10.1371/journal.pone.0238135.t001
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astigmatism among the three groups (P = 0.072 and P = 0.43, respectively, the Kruskal-Wallis
test). In the axial length and IOL power, the EE group differed significantly (P<0.0066 and
P<0.017, respectively, the Steel-Dwass multiple comparison test) from the other groups. There
were eyes of corneal astigmatism of 1.71 and 1.72 D in the MM and EM groups, respectively,
the postoperative cylinders resulted in 1.25 and 0.0 D by adjusting the incision positions.
Table 2 shows the postoperative MRSEs in the 3 groups. For the eyes targeted to emmetro-
pia (N = 65) and -0.5 D (N = 63), the mean MRSEs were -0.23 D (standard deviation [SD]:
0.44 D, range: -1.50–1.00 D) and -0.51 D (SD: 0.37 D, range: -1.38–0.38 D), respectively. There
was no significant difference between the EE group and the emmetropia targeted in the EM
group (P = 0.44, t-test), while the MRSEs in the MM group were significantly (P = 0.047)
higher than those in the -0.5-D-targeted eyes in the EM group. Fig 2 shows the histograms of
Table 2. Postoperative manifest refractions spherical equivalent (MRSE) in the three groups.
Group EE (N = 44 eyes) MM (N = 42 eyes) EM (N = 21 eyes each)
MRSE (D), range
Emmetropia targeted -0.26 ± 0.48, -1.50 to 1.00 - -0.17 ± 0.34, -0.75 to 0.50
-0.5 D targeted - -0.44 ± 0.35, -1.13 to 0.38 -0.64 ± 0.39, -1.38 to 0.00
Eyes within ± 0.3 D from target refractions
Monocular, -0.3 to 0.3 D, eye 23 (52.3%) - 12 (57.1%)
Monocular, -0.8 to -0.2 D, eye - 26 (61.9%) 12 (57.1%)
Binocularly, patient 10 (45.5%) 8 (38.1%) 9 (42.9%)
The data are expressed as the mean ± standard deviation.
EE = bilateral emmetropia; MM = bilateral -0.5 D bilaterally; EM = monovision of emmetropia and -0.5 D; D = diopters.
https://doi.org/10.1371/journal.pone.0238135.t002
Fig 2. Histograms of postoperative manifest refraction spherical equivalent in three groups. Group EE: bilateral emmetropia, group MM: bilateral -0.5
diopters, and Group EM: monovision of emmetropia and -0.5 D.
https://doi.org/10.1371/journal.pone.0238135.g002
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the MRSEs [15]. There were peaks at emmetropia (-0.13 to 0.13 D) and the range of -0.50 to
-0.13 D, while the EM resulted in broad peaks in the range of -1.00 to +0.13 D. Hyperopia
were found in 2% to 5% in each group.
As shown in Table 2, 42.9% to 61.9% of the monocular eyes were within ± 0.3 D of the tar-
geted refractions; however, only 38% to 45% of patients achieved binocularity. The mean
refractive cylinders in the EE, MM, and EM groups were 0.44, 0.50, and 0.45 D (SD: 0.42, 0.42,
and 0.43 D), respectively, and there was no significant difference between the groups (P = 0.84,
the Kruskal-Wallis test).
Fig 3 shows the BUCVAs from 0.3 to 5.0 meters. No differences were found among the
three groups (P>0.23). The mean BUCVA was 0.0 logMAR (20/20 in Snellen notation) or bet-
ter at 0.7 meter or longer in the EE group and 0.5 meters or longer in the MM and EM groups.
The histogram of the BUCVA at each distance is shown in Fig 4 [15]. 20/20 or betters was
achieved in more than 55% of patients, and it degraded at nearer distances drastically in the
EE group.
Fig 3. Binocular uncorrected visual acuities from 0.3 to 5.0 meter in three groups. Group EE: bilateral emmetropia, group MM: bilateral -0.5
diopters, and Group EM: monovision of emmetropia and -0.5 D. No significant differences are seen among the groups. logMAR = logarithm of the
minimum angle of resolution.
https://doi.org/10.1371/journal.pone.0238135.g003
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In the EE, MM, and EM groups, 7(31.8%), 12(57.1%), and 11(52.4%) of patients did not use
spectacles, a difference that did not reach significance (P = 0.13, Fisher’s exact test) among the
groups.
The postoperative stereopsis were obtained in 22, 20, and 20 patients, and resulted in 53,
57, and 55 (SD: 23, 31, and 28) seconds of arc in the EE, MM, and EM groups, respectively.
There was no significant difference (P = 0.70) among the groups. The rates in the normal
range (100 seconds of arc or less) [11] were 95.5% (21 patients), 90.0% (18 patients), and
95.0% (19 patients), respectively.
Table 3 shows the scores of the photic symptoms and patient satisfaction in each group.
Except for the satisfaction with closer distances such as when reading a book and using a smart
phone, scores of 3 or 4 or higher were obtained. No significant (P>0.65) differences were
found among the groups.
Based on the MRSE, 16 and 12 patients were assigned to the EE and MM groups, respec-
tively. Fig 5 show the mean of the BUCVAs of the 2 groups The EE group showed a signifi-
cantly better at 5 m (P = 0.005, Man-Whitney test) and the mean difference was 0.09 logMAR.
Fig 4. Histograms of binocular uncorrected visual acuities at distances of 5, 1, 0.7, 0.5, 0.4, and 0.3 meter in three groups. EE: bilateral emmetropia,
group MM: bilateral -0.5 diopters, and Group EM: monovision of emmetropia and -0.5 D.
https://doi.org/10.1371/journal.pone.0238135.g004
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Table 3. Mean scores of photic symptom and patient satisfaction�.
Group EE MM EM P Value†
Photic symptom
Glare 2.9 ± 0.9 3.0 ± 0.9 3.0 ± 0.9 0.70
Halo 3.0 ± 0.9 3.0 ± 1.0 3.0 ± 1.1 0.94
Starburst 2.9 ± 1.1 3.0 ± 0.9 3.0 ± 1.2 0.77
Waxy vision 3.5 ± 0.9 3.8 ± 0.4 3.5 ± 0.9 0.85
Satisfaction
Far vision 3.3 ± 0.6 3.2 ± 0.7 3.0 ± 0.9 0.65
Intermediate vision 3.3 ± 0.5 3.2 ± 0.4 3.2 ± 0.7 0.88
Near vision 3.0 ± 0.5 3.0 ± 0.3 3.0 ± 0.9 1.00
Close vision 2.5 ± 0.7 2.5 ± 0.8 2.6 ± 0.9 0.96
Total 3.3 ± 0.5 3.3 ± 0.6 3.1 ± 0.9 0.73
The data are expressed as the mean ± standard deviation.
�The scores range from 1 (worst) to 4 (best).
†: the Kruskal-Wallis test.
https://doi.org/10.1371/journal.pone.0238135.t003
Fig 5. Binocular uncorrected visual acuities from 0.3 to 5.0 meter in the patients obtained the postoperative refractions in the ranges of -0.25 to
+0.25 D (EE group) and -0.75 to -0.25 D (MM group) bilaterally. Significant differences were found at 5 m and 0.5 m (P = 0.005 and 0.031, the
Mann-Whitney U-test). logMAR = logarithm of the minimum angle of resolution.
https://doi.org/10.1371/journal.pone.0238135.g005
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Discussion
In the staged implantations of the IOL with the two targeted refractions, there were no differ-
ences in the BUCVA, stereopsis, photic symptoms, or patient satisfaction among the EE, MM,
and EM groups. In a previous multicenter study, monovision targeting emmetropia and myo-
pia (approximately -0.5 D) in 112 patients improved significantly in the BUCVAs at 0.4 and
0.7 m compared with the 299 patients in which bilateral emmetropia was targeted [5], as
shown in Table 4. The mean MRSEs in the eyes targeted for -0.5 D resulted in -0.75 D, which
could be most effective for monovision [6]. The current comparison between the EE and MM
groups based on the MRSE showed that there was a significant difference at 0.5 m, as well.
Thus, we speculated that the discrepancies with the previous study were due to the resultant
MRSE in the eyes targeting for -0.5 D.
The EM group did not show the effect of monovision in the current results. It would be one
of the factors that the subject size was not sufficiently large to distinguish between the EE and
MM groups. The mean difference in the MRSE was 0.47 D, while Cochener reported that the
best effect of monovision was obtained with the ZXR00 IOL when the MRSE difference was
0.75 D [6]. Further prospective evaluation is required.
Relatively large variations in the MRSEs were seen. The SDs of 0.34 to 0.48 D were compa-
rable to differences in the targeted refraction (0.5 D), and only 38.1% to 45.5% of patients
obtained binocular MRSEs within ± 0.3-D error. More accurate IOL power calculation is nec-
essary to successfully achieve monovision with the EDOF IOLs. While current conventional
IOL power calculations using optical biometry have been available, refractive errors within 0.5
D can be obtained in about 70% of eyes [13–16]. This result suggests that such refractive errors
would be achievable binocularly in about 50% of patients, which agreed well with the current
results. With the use of an advanced power calculation formula such as the Barrett Universal
II, a refraction error within 0.25 D would be obtained in half of the eyes [16]. These findings
suggested that targeting of emmetropia and -0.5 D was difficult to achieve, so that the effect of
monovision would not be anticipated. We concluded that a larger difference in the targeting,
such as emmetropia and a -0.75 D, would be practical.
There was no difference in the spectacle use, stereopsis, photic symptom, and patient satis-
faction among the three groups. The spectacle use, photic symptom, and patient satisfaction
Table 4. Comparison of binocular uncorrected visual acuities in a previous study [5] with the current results.
Targeted refractions Bilateral Emmetropia Emmetropia and -0.5 D P Values
Far
Previous [5] 0.03 ± 0.09 0.04 ± 0.11 0.49
Current -0.14 ± 0.08 -0.11 ± 0.08 0.14
0.7 meter
Previous [5] 0.13 ± 0.16 0.09 ± 0.17 0.003
Current -0.05 ± 0.11 -0.06 ± 0.09 0.95
0.4 meter
Previous [5] 0.21 ± 0.16 0.17 ± 0.18 0.011
Current 0.13 ± 0.13 0.21 ± 0.16 0.13
MRSE, D
Previous [5] -0.30 ± 1.13 -0.21 ± 0.38 and -0.75 ± 0.52
Current -0.26 ± 0.48 -0.17 ± 0.34 and -0.64 ± 0.39
The data are expressed as the mean ± standard deviation.
D = diopters; MRSE = manifest refraction spherical equivalent.
https://doi.org/10.1371/journal.pone.0238135.t004
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were similar to those reported in the previous studies [6,7]. The stereopsis did not change
when diffractive bifocal IOLs of different add powers were implanted bilaterally [12]. Target-
ing a -0.5 D was insufficient for modifying the BUCVA at intermediate and near distances, so
that the effect should be less.
The current study had limitations. The sample sizes were not the same among the three
groups. In the study design of staged implantation, it was not easy to adjust the sample sizes to
accommodate the patients’ preferences. However, the current results showed the reality of tar-
geting of a -0.5 D in the use of EDOF IOLs. Another limitation was the accuracy of the IOL
power calculations. We used the SRK/T formula with biometric measurements together with
spectrum-domain biometry. However, only half of the subjects had refractive errors
within ± 0.3 D. Although the current biometry and IOL power calculation methodology has
become advanced, the achieving 0.25 D differences would be still challenging. Furthermore, it
was difficult to evaluate the effect of a -0.5-D refraction. Cochener [6] suggested in a retrospec-
tive analysis that targeting of -0.75 D would be better and more realistic to achieve. A prospec-
tive assessment of -0.75 D targeting is required to verify the effects.
In conclusion, targeting of -0.5 D in the use of an EDOF IOL resulted in similar outcomes
with the emmetropic targeting due to the insufficient accuracy in the current IOL power calcu-
lations. Targeting a lower refraction such as -0.75 D would be more practical and effective for
patients with bilateral implants.
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